LOS ANGELES--(BUSINESS WIRE)-- Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular ...
LOS ANGELES--(BUSINESS WIRE)--Kernel, an innovator in non-invasive neuroimaging technology, announces the first patient has been measured in an observational study of depression treatments using ...
Biohacker Bryan Johnson invested $60 million into a brain-tracking headset. How well does it work?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results